Skip to content

Stress Sensitivity and Reward Responsivity in Depression

Stress Sensitivity and Reward Responsivity: An Integration of Two Endophenotypes in Major Depression

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02798094
Acronym
CAN-BIND-04
Enrollment
219
Registered
2016-06-14
Start date
2015-07-31
Completion date
2018-12-31
Last updated
2019-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressed

Brief summary

The goal of this project is to learn more about the different ways in which people process information that is stressful and rewarding, and how abnormalities in these two processes are related to depression.

Detailed description

Participants will participate in two 3-hour sessions separated by a week at Providence Care, Mental Health Services, and a third, 1.5-hour session at the Queen's MRI Facility. At the first session participants will complete a packet of questionnaires about their mood and take part in an interview about their mood, medications, drug use, and any other symptoms, as well as an interview about their relationships with their parents and any experiences of abuse. At the second session participants will participate in a stress test, which involves giving a speech to a panel. The investigators will also collect saliva samples to look at stress hormones. Participants will also complete a task on the computer that involves looking at cartoon faces and making decisions about them. At the third session, the investigators take images of of participant's brain using a magnetic resonance scanner. Participants are invited to participate in a 6-month follow-up for this study, which would involve the same procedure as outline above.

Interventions

None listed

Sponsors

University Health Network, Toronto
CollaboratorOTHER
University of Calgary
CollaboratorOTHER
Harvard University
CollaboratorOTHER
McGill University
CollaboratorOTHER
Dr. Kate Harkness
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

For Depressed Participants: Inclusion Criteria: * Outpatients aged 18-65 * Currently suffering from unipolar depression * Fluency in English, sufficient to complete the interviews and self-report questionnaires

Exclusion criteria

* Clinical diagnosis of bipolar disorder, psychotic disorders, current alcohol/substance dependence, or significant medical comorbidity * Treatment-resistant (defined as failing more than 3 trials of anti-depressant medication) * History of neurological insult (e.g., concussion), neurological disease, seizure disorder * Smokers * Pregnant women * Endocrine disorders * High suicidal risk, defined by clinician judgement For Healthy Control Participants: Inclusion Criteria: * Adults aged 18-65 * No history of Axis I disorders according to DSM-IV-TR criteria, as determined by the SCID * No first-degree relatives diagnosed with bipolar disorder * Fluency in English, sufficient to complete the interviews and self-report questionnaires

Design outcomes

Primary

MeasureTime frameDescription
Stress Sensitivity: Salivary Hormone and Stress Challenge Test (TSST)2 hours after beginning of Time B AppointmentParticipants are required to give a speech and an arithmetic test in front of a panel. Saliva samples are collected at 8 points throughout the test.

Secondary

MeasureTime frameDescription
Mood and Anxiety Symptom Questionnaire (MASQ)Administered at first baseline appointment and covers past 2 weeksSelf-report scale of general distress (GD), anhedonic depression (AD), and anxious arousal (AA) symptoms
Reward Responsivity: Probabilistic Reward TaskAdministered at second baseline appointmentComputerized task that requires participants to choose between two stimuli and develop a response bias to the more frequently rewarded stimulus.
Snaith Hamilton Pleasure Scale (SHAPS and SHAPS-C)Administered at first baseline appointment and covers past 2 weeks prior to interviewSelf-report of anhedonia symptoms

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026